Tremelimumab and durvalumab therapy in lung cancer
Using MammaPrint to select patients who may not need adjuvant chemotherapy – the results of MINDACT
ARASENS: Will combining different treatments improve prostate cancer survival?
Novel targets and biomarkers in mesothelioma
The difficulties in treating squamous cell lung cancer